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Abstract
Background—Evidence concerning the association of anger-proneness with incidence of heart 
failure is lacking.
Methods—Anger proneness was ascertained among 13,171 black and white participants of the 
Atherosclerosis Risk in Communities (ARIC) Study cohort using the Spielberger Trait Anger 
Scale. Incident heart failure events, defined as occurrence of ICD-9-CM code 428.x, were 
ascertained from participants’ medical records during follow-up 1990–2010. Relative hazard of 
heart failure across categories of trait anger was estimated from Cox proportional hazard models.
Results—Study participants (mean age 56.9 (SD 5.7) years) experienced 1,985 incident HF 
events during 18.5 (SD 4.9) years of follow-up. Incidence of HF was greater among those with 
high, as compared to those with low or moderate trait anger, with higher incidence observed for 
men as compared to women. The relative hazard of incident HF was modestly high among those 
with high trait anger, as compared to those with low or moderate trait anger (age-adjusted HR for 
men=1.44 (95% CI 1.23, 1.69). Adjustment for comorbidities and depressive symptoms attenuated 
the estimated age-adjusted relative hazard in men to 1.26 (95% CI 1.00, 1.60).
Conclusion—Assessment of anger proneness may be necessary in successful prevention and 
clinical management of heart failure, especially in men.
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Extensive evidence from existing studies underscores the role of emotional factors in the 
development of cardiovascular disease. The focus of the present study is trait anger, defined 
as sustained low threshold reactivity in which angry feelings, which can vary from mild 
irritation to extreme rage, are experienced in response to broadly defined triggers1–3. Trait 
anger as a construct shows considerable overlap with a hostile disposition4 and may include 
anger-related affect, behavior, and cognition5.
Multiple mechanisms have been proposed to explain the biological and behavioral aspects of 
the association of trait anger with cardiovascular disease. An anger-prone personality may 
lower a person’s self-esteem and limit his or her ability to engage in constructive activities 
aimed at health improvement6. On the biological level, sustained anger can lead to 
chronically increased catecholamine levels 7, which in turn can trigger an inflammatory 
response, leading to the progression of atherosclerosis and eventually to clinically 
manifested heart disease 8.
Anger proneness confers significant risk for coronary heart disease (CHD)9–14 and stroke15 
with effects that can be observed at the subclinical level16–18. Relatively little is known 
about the association of anger with the risk of heart failure19 and with utilization of 
healthcare resources among those with heart failure20. Repeat hospitalizations are frequent 
among those with heart failure, and contribute significantly to costs of care21. With 
increasing prevalence of heart failure, more research is needed to identify modifiable 
factors, other than disease severity and presence of comorbidities, which may contribute to 
preventable hospital readmissions. In this study, we examined the association of anger-
proneness with the incidence of heart failure and with subsequent healthcare utilization 




The ARIC study cohort was established in 1987 as a probability sample of 15,792 men and 
women, aged 45 to 64 years, from the following four communities in the United States: 
suburbs of Minneapolis, Minnesota; Forsyth County, North Carolina; Washington County, 
Maryland; and Jackson, Mississippi. Extensive physical examinations were performed at 
baseline and at four subsequent clinic visits. Ongoing follow-up of the ARIC cohort is 
conducted through annual telephone interviews and surveillance of mortality and 
cardiovascular morbidity.
Participants of the ARIC cohort were selected for the present study if they completed the 
second physical examination (1990–1992) (n=14,348). Due to numbers that are too small to 
allow for adequate adjustment, excluded from analyses were study participants whose race 
was other than black or white (n=42) and black study participants from the Minnesota and 
Washington (n=49) ARIC study centers. Excluded from analyses were also study 
participants with prevalent HF at the second ARIC examination. Prevalent events were 
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ascertained from information obtained at the study baseline examination (1987–1989) and 
classified using Gothenburg HF classification criteria (n=753) and in follow-up of heart 
failure hospitalizations from the baseline examination to the second ARIC examination 
(n=86). Further excluded from analyses were study participants with missing outcome, 
exposure and key covariate information. The final study sample size was 13,171.
Event ascertainment
Incidence of hospitalized heart failure (HF) events was ascertained in follow-up from the 
date of the second ARIC examination (1990–1992) through December 31, 2010 on the basis 
of evidence of ICD-9-CM code 428.x in any position in the study participants’ medical 
records. A HF hospitalization was defined as incident if no prevalent HF was recorded at the 
time of the baseline visit (ARIC Visit 2) and no HF-related hospitalizations (hospitalizations 
with ICD-9 code 428.x in any position) were observed in surveillance of all hospitalized 
events that the ARIC study conducts for all cohort participants. Prevalence of HF at the 
baseline visit was defined as (1) self-report of use of HF-related medications; (2) presence of 
HF classified according to Gothenburg criteria or missing information needed to define 
Gothenburg stage22; or (3) having had a hospitalization with ICD-9 428.x prior to the 
baseline (ARIC Visit 2) clinical examination. Death events were identified from linked 
National Death Index records and information provided by physicians and next of kin. All-
cause hospital readmissions for study participants with incident HF events were identified 
from their hospital discharge records available through December 31, 2010.
Measurement of anger proneness
Information on anger proneness was obtained on the basis of the Speilberger Trait Anger 
Scale which was administered during an interview conducted as part of the second ARIC 
examination (1990–1992). This questionnaire, which consists of 10 items with responses 
graded on a Likert-type scale (range 10–40), shows high internal consistency ( Cronbach’s 
α=0.86)23. Factor analyses suggest that the scale consists of two components which assess 
anger temperament and anger reaction, with the final score representing the sum of 
responses for the these two subscales. In accordance with previous assessments of anger 
proneness with cardiovascular outcomes that has been conducted in the ARIC 
study11, 12, 15, 17, 18, anger proneness was categorized as: (1) low anger (score: 10–14); (2) 
moderate anger (score: 15–21); and (3) high anger (score: 22–40).
Measurement of covariates
Physical examination of the cohort members and assessment of their risk factors, other than 
demographic, were conducted during the second ARIC examination. Gender and race were 
self-reported at the time of the first ARIC examination. Highest attained level of education 
was defined on the basis of a personal report at baseline of the highest grade completed in 
school and categorized as low (11th grade or less) or high (12th grade and above). At the 
first examination, ARIC study participants were asked to classify their total family income 
into one of the following eight categories: <$5000; $5000–$7999; $8000– $11 999; $12 
000–$15 999; $16 000–24 999; $25 000–34 999; $35 000–$49 000; ≥$50 000. We collapsed 
these categories into three groups labeled as low (less than $15 999), medium ($16 000 to 
$34 999) and high (equal to or greater than $35 000). At the second ARIC examination 
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(considered baseline for the purposes of this study), members of the ARIC cohort had blood 
drawn from an antecubital vein into tubes containing EDTA (lipids), or a separating gel 
(glucose). Presence of a diagnosis of diabetes at the time of the clinical examination was 
based on any of the following: self-report of a physician’s diagnosis of diabetes, self-report 
of use of hypoglycemic medication within two weeks of the ARIC examination, fasting (> 8 
hours) blood glucose levels greater than 126 mg/dL, or non-fasting blood glucose levels 
greater than 200 mg/dL. Body mass index was calculated as the ratio of weight in kilograms 
to the square of height in meters. Sitting blood pressure was measured three times using a 
random zero sphygmomanometer. Blood pressure calculations were made as an average of 
the second and third measurement. Hypertension was defined as present based on self-
reported use of antihypertensive medication within two weeks of baseline data collection or 
if systolic blood pressure measured at baseline was greater than or equal to 140 mm Hg, or 
diastolic blood pressure was greater than or equal to 90 mm Hg. Prevalence of coronary 
heart disease (CHD) at ARIC Visit 2 (baseline for the present study) was ascertained on the 
basis of a self-reported history of CHD and evidence of an adjudicated CHD hospitalization 
from ARIC Study baseline to Visit 2.
Plasma HDL-cholesterol levels were measured using the method of Warnick et al24. Total 
plasma cholesterol levels were determined enzymatically25 using a Cobas-Bio analyzer with 
reagents purchased from Boehringer Mannheim Biochemicals. Plasma LDL–cholesterol 
levels were calculated using the method of Friedewald26. Self-reported vital exhaustion was 
assessed using a 21-item Maastricht Vital Exhaustion questionnaire developed by Appels et 
al.27. The continuous vital exhaustion scale (range: 0–42) was created on the basis of 
questions concerning participants’ state of fatigue, lack of energy, feelings of hopelessness, 
loss of libido, and increased irritability. The Maastricht Vital Exhaustion questionnaire is 
highly correlated with validated depression scales (r=0.61–0.85)28, 29, including the Beck 
Depression Inventory (r=0.62)30. To account for the non-normal distribution of the vital 
exhaustion scale in the ARIC Study population, we categorized responses to this 
questionnaire into quartiles based on the distribution and used the highest quartile, relative 
to quartiles 1–3, as the exposure category31.
Statistical analyses
Cox proportional hazard regression of the association of trait anger and incidence of HF was 
performed with evaluation of the following covariates for inclusion into the model: age, 
race/center, body mass index, gender, cigarette years of smoking, cigarette smoking status, 
diabetes status, hypertension status, and depression. Inclusion of variables into the model 
was based on the 10% change-in-estimate criterion32. The Jackson, MS component of the 
ARIC cohort is exclusively African American. The only other ARIC field center with a 
sizeable proportion of African Americans is Forsyth County, NC (27%). A categorical race/
center variable encompassing 5 categories of race and ARIC field center was created to 
account for these demographic distributions.
We used partial likelihood ratio tests based on nested models that included multiplicative 
interaction terms to examine whether the risk of HF in association with trait anger differed 
by race, gender, and other selected covariates. All continuous variables were evaluated for 
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linearity of association with the main outcome using regression analyses with log hazard 
ratios plotted as a function of the exposure categorized into quintiles of distribution. Cox 
proportional hazard assumptions were examined for all variables individually and for the 
final model using the Cox test, the ln-ln plots, and plots of scaled Schoenfeld residuals. All 
time-to-event analyses were performed with consideration of competing risk of death 
performed according to the method of Allison33. Age-adjusted multinomial regression 
models were used to evaluate the relative risk of heart failure in addition to the relative risk 
of coronary heart disease, stroke among ARIC cohort participants. All analyses were 
conducted using STATA 12.0 (College Station, TX) and SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
Study participants in the three categories of trait anger (low, moderate, and high) did not 
differ significantly by hypertension status, diastolic blood pressure levels and by cholesterol 
measures (Table 1). Small, although statistically significant differences were observed 
across trait anger categories with respect to gender, race, education level, hypertension and 
diabetes. Proportion of men and of those with less than high school education was highest 
among those with high trait anger as compared to those with moderate and low trait anger. 
Proportion of blacks was lowest among those with moderate anger. Proportion of study 
participants with diabetes was likewise the lowest among those with moderate trait anger. 
Systolic blood pressure levels were lowest among those with moderate trait anger, whereas 
participants’ mean BMI levels increased across trait anger categories.
For purposes of this study, the second ARIC examination was considered as the baseline. 
There were 1,985 incident heart failure events identified in this cohort during mean 18.5 (SD 
4.9) years of follow-up from baseline through December 31, 2010. Cumulative hazard of HF 
was greater in those with high trait anger as compared to those with moderate or low trait 
anger (Figure 1). This observation was independent of whether analyses were performed 
with or without consideration of the competing risk of death (presented data reflect analyses 
performed with consideration of competing risk of death).
Age-adjusted incidence of HF increased in the highest category of trait anger from 9.8 (95% 
CI 9.2, 10.4) per 1,000 person-years among those with low trait anger and 9.5 (95% CI 8.9, 
10.2) per 1,000 person-years among those with moderate trait anger, to 13.3 (95% CI 11.4, 
15.2) per 1,000 person-years among those with high trait anger (Figure 2). HF incidence 
rates were very similar in the low and moderate trait anger categories across levels of 
covariates of interest. Incidence of HF increased for those with high trait anger as compared 
to those with low or moderate trait anger in all gender and race categories, with the 
exception of black women. The highest rate of HF was observed among black men with 
high trait anger.
The relative hazard of incident HF was modestly high among those with high trait anger, as 
compared to those with low or moderate trait anger (age-adjusted HR=1.44 (95% CI 1.23, 
1.69) (Table 2). We observed effect measure modification of this association by gender and 
accordingly stratified all analyses by gender. In analyses adjusted for race, education and 
income, the greatest hazard ratio of incident HF was observed among men (HR=1.52 (95% 
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CI 1.23, 1.88)). Additional adjustment for baseline diagnosis of diabetes, hypertension, and 
prevalent CHD attenuated the observed hazard ratio in men to 1.37 (95% CI 1.11, 1.70). 
Adjustment for vital exhaustion further attenuated the overall hazard ratio to 1.16 (95% CI 
0.98, 1.39) and in men to 1.26 (95% CI 1.00, 1.60).
We constructed age-adjusted multinomial models to simultaneously evaluate the relative 
risk of HF, coronary heart disease and stroke in relation to levels of anger proneness (data 
not shown). Results of this analysis suggest that while high, as compared to low, anger 
proneness was associated with greatest risk of stroke (73% excess risk), high anger 
proneness conferred a comparable increase in the risk of coronary heart disease (60% excess 
risk) and heart failure (43 % excess risk). The differences in the relative risk estimates for 
these three different clinical manifestations of cardiovascular disease were not significant.
During follow-up from the time of incident HF hospitalization (mean follow-up time: 4.3 
years (SD 4.0)) 1,596 ARIC cohort participants (80.4%) experienced a re-hospitalization 
event (all-cause). The proportion of participants with at least one hospital readmission 
increased from 79.9% among those with low trait anger to 82.0% among those with high 
trait anger (Table 3). The average number of hospital readmissions during the follow-up 
period was 4 (interquartile range (IQR): 2, 7). Number of readmissions did not vary across 
categories of trait anger. Proportion of those with a first readmission occurring within 30 
days of index HF hospitalization was 31.2% overall. This proportion increased across trait 
anger categories from 30.1% among those with low trait anger to 33% among those with 
high trait anger. The median time to first readmission was 133.5 days (IQR: 30,530), with 
138 (IQR: 33, 535) observed for those with low trait anger and 124 (IQR: 28, 510) observed 
for those with high trait anger. No differences were observed across categories of trait anger 
in age-adjusted length of stay (results not shown). In multivariable analyses, with adjustment 
for age, race, gender, diabetes, and education (Table 4), the relative risk of all-cause 
readmission was marginally increased among those with high anger as compared to those 
with low and moderate anger (HR= 1.19 (95% CI 1.00, 1.22)). Similar estimates for the 
associations of trait anger with the risk of readmission were obtained from analyses limited 
to HF-related re-hospitalizations (ICD-9 code 428.x in any position, as well as ICD-9 code 
428.x in the first position on the medical record; data not shown). All analyses were adjusted 
for competing risk of death.
DISCUSSION
Despite efforts to reduce the prevalence of cardiovascular disease risk factors, incidence of 
heart failure remains high34 and healthcare utilization among those with heart failure 
constitutes the single largest healthcare expenditure among those 65 years of age and 
older35. In an attempt to look beyond the obvious in identifying factors that may reduce 
heart failure incidence and improve outcomes for those with heart failure, we examined the 
effect of anger proneness on heart failure incidence and on hospital readmissions following 
incident HF diagnosis.
Anger management styles can be broadly categorized as (1) trait anger characterized by a 
sustained inclination towards an angry response; (2) anger-out manifested by a direct 
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expression of anger at others; and (3) anger-in, a suppression of angry emotions3. The focus 
of this study was trait anger. We observed a modest positive association of high trait anger 
with the incidence of heart failure. The observed risk was independent of the level of 
attained education, income and comorbidity status. We observed gender and race differences 
in the association of trait anger with the incidence of heart failure hospitalization, with a 
persistent association noted among black men. No increased risk of the incidence of heart 
failure was observed among women with high, as compared to low, trait anger. This 
observation is consistent with the results of the few existing studies which have examined 
gender-specific effects of anger on the risk of cardiovascular disease10, 17, 36, 37. Results of 
those studies suggest a stronger harmful effect of anger on coronary heart disease events 
among men, as compared to women, perhaps reflecting the predominance of outward 
expression of anger among men (anger-out) and the extent to which this anger coping style 
may be associated with greater risk of cardiovascular disease. To our knowledge the present 
study is the first to examine gender differences in the association of anger with the risk of 
heart failure.
Previous studies have demonstrated an association of depressive states with heart failure 
hospitalization38. We found that although presence of depressive symptoms, approximated 
on the basis of responses to the Maastricht Vital Exhaustion questionnaire, attenuated the 
association of trait anger with heart failure incidence, it explained only a portion of the 
variance. Contrary to the expectation that depression, a dominant factor in patients’ coping 
with cardiovascular disease37, would be significant in the association of anger with 
healthcare utilization among those with heart failure, we found no effect of the presence of 
depressive symptoms on the association of trait anger with the risk of all-cause hospital 
readmission. However, it is possible that the observed overall effect of anger on the risk of 
hospital readmission was too small for a meaningful assessment of potential covariates. 
Further, fatigue, feelings of demoralization, and irritability which were measured by the vital 
exhaustion questionnaire may not have provided a full ascertainment of study participants’ 
depressive status.
Our findings of the association of trait anger with heart failure are consistent with previous 
research indicating a positive association of anger with clinical CVD risk factors39, 40 and 
with clinical CVD outcomes other than heart failure10. Mechanisms involved in this 
association are complex and the present study was not designed to elucidate those. 
Nevertheless, our results are consistent with research such as that of Ironson et al.41 which 
points to an association of psychological stressors, including that of anger, with low left 
ventricular ejection fraction. This research makes plausible the theory that autonomic 
dysfunction observed as part of the anger response42 affects downstream arterial remodeling 
and subsequent myocardial ischemia which can in turn lead to cardiac insufficiency and 
heart failure.
Our results suggest that the risk of heart failure among those with high, as compared to low, 
anger proneness is similar to their risk of stroke or coronary heart disease and emphasizes 
the need for the evaluation of psychosocial risk factors in overall primary and secondary 
prevention of cardiovascular disease.
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The present study suggests that the effect of trait anger extends beyond the initial 
hospitalization for heart failure. We observed a 19% greater risk of all-cause hospital 
readmission following incident HF hospitalization among those with high trait anger as 
compared to those with low trait anger. This increased risk was independent of the metabolic 
and sociodemographic cardiovascular disease risk factors. To our knowledge, only one other 
study examined the association of anger with the use of healthcare services among heart 
failure patients20. In that small prospective clinical study of heart failure patients, the 
authors concluded that high trait anger was predictive of increased length of stay during 
hospital readmissions. Results of our study, however, do not support that observation – we 
did not observe differences across categories of trait anger in length of stay during the first 
hospital readmission. Healthcare organizations are under increasing pressure to decrease the 
number of hospital readmissions and associated length of stay in an effort to reduce costs 
and improve clinical outcomes. Readmission rates following a HF hospitalization discharge 
approach 24% and have remained stable21, 43, despite multiple hospital and practice-based 
efforts to improve quality of care for patients with HF. A multifaceted approach to the 
identification of factors associated with hospital readmission among those with HF is 
therefore necessary for implementation of targeted prevention. We chose to examine all-
cause re-hospitalization among those with HF as recurrent HF and cardiovascular disease 
hospitalizations account for only approximately half of all hospital readmissions among 
those with HF, with comorbid conditions accounting for the remaining large proportion of 
re-hospitalizations44, 45.
Several strengths and limitations of this study should be noted. This is the largest biracial 
study to date to examine the association of anger with the incidence of HF. Research 
concerning the effect of anger on HF incidence and outcomes is rare. The majority of 
existing studies were conducted using small patient populations. The prospective nature of 
the ARIC study has allowed for an extended follow-up period from the measurement of 
anger proneness. We ascertained anger proneness using a questionnaire known to have a 
high internal consistency (0.86) and high test-retest reliability (0.77)46 and which has been 
validated in multiple other populations. Evaluation of risk factors at study baseline, 
performed using established protocols, was thorough and allowed for detailed assessment of 
comorbidity status of study participants. An important limitation of this study was that 
ascertainment of HF events was limited to HF-related hospitalizations. Although a 
significant proportion of HF events is diagnosed and treated in the outpatient setting, 
comprehensive assessment of HF events occurring in the outpatient setting is beyond the 
scope of current ARIC study protocols. We were not able to ascertain medication use at the 
time of the HF hospitalization, therefore we could not provide potentially explanatory 
information on the role of hypertension in the association of trait anger with the risk of HF, 
beyond that available from baseline data. The potential social response desirability bias of 
the self-report of anger proneness could have resulted in an underestimation of trait anger.
In conclusion, we observed a modest association of trait anger with heart failure incidence, 
and with the risk of subsequent re-hospitalization. Results of this study suggest that 
inclusion of anger management may be necessary in successful prevention and clinical 
management of heart failure. This intervention may be more significant for men as 
compared to women.
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Table 1











Age, years, mean (SD) 57.4 (5.8) 56.7 (5.7) 56.5 (5.8) <0.01
Gender, % men 43.8 45.1 51.0 <0.01
Race, % Black 27.2 21.5 24.8 <0.01
Education, <HS, % 22.1 18.9 29.9 <0.01
Income
  Low, % 20.6 16.2 22.4
  Medium, % 31.2 31.4 33.9
  High, % 48.3 52.0 43.7 <0.01
Hypertension, % 34.9 33.1 35.5 0.07
Diabetes, % 14.3 13.6 17.5 <0.01
Vital exhaustion, % 42.6 54.2 76.8 <0.01
Prevalent CHD, % 4.3 4.8 8.8 <0.01
Systolic BP, mmHg (SD) 122 (19) 120.7 (18) 121.8 (18.8) 0.03
Diastolic BP, mm Hg (SD) 72.3 (10.3) 72 (10.1) 72.2 (10.5) 0.27
Total cholesterol, mg/dL (SD) 5.42 (1.03) 5.43 (1.00) 5.40 (1.05) 0.81
LDL cholesterol, mg/dL (SD) 3.45 (0.96) 3.45 (0.94) 3.44 (0.95) 0.86
HDL-cholesterol, mg/dL (SD) 1.30 (0.43) 1.28 (0.43) 1.25 (0.44) 0.03
Triglycerides, mg/dL (SD) 1.49 (1.00) 1.53 (0.98) 1.58 (1.05) 0.01
BMI, kg/m2 (SD) 27.7 (5.3) 27.8 (5.3) 28.3 (5.3) <0.01
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Table 2
Association of trait anger with incident heart failure*. The ARIC Study cohort, 1990–2010.
Low anger Moderate anger High anger
n=4,880 n=7,263 n=1,028
Model 1
Total (n=13,171) 1 0.97 (0.88, 1.06) 1.32 (1.13, 1.54)
Women (n=7,234) 1 0.98 (0.86, 1.12) 1.07 (0.83, 1.39)
Men (n=5,937) 1 0.94 (0.82,1.08) 1.46 (1.19, 1.79)
Model 2
Total 1 1.03 (0.94, 1.13) 1.44 (1.23, 1.69)
Women 1 1.06 (0.93, 1.22) 1.21 (0.94, 1.56)
Men 1 0.98 (0.86, 1.13) 1.55 (1.26, 1.90)
Model 3
Total 1 1.06 (0.96, 1.17) 1.37 (1.16, 1.61)
Women 1 1.06 (0.93, 1.232) 1.06 (0.82, 1.33)
Men 1 1.05 (0.91, 1.21) 1.52 (1.23, 1.88)
Model 4
Total 1 1.04 (0.94, 1.14) 1.23 (1.04, 1.45)
Women 1 1.07 (0.93, 1.23) 1.00 (0.76, 1.30)
Men 1 1.00 (0.87, 1.15) 1.37 (1.11, 1.70)
Model 5
Total 1 0.97 (0.86, 1.08) 1.16 (0.98, 1.39)
Women 1 0.96 (0.83, 1.12) 1.02 (0.78, 1.33)
Men 1 0.96 (0.82, 1.14) 1.26 (1.00, 1.60)
*
Estimates adjusted for competing risk of death.
Model 1: unadjusted
Model 2: adjustment for age
Model 3: adjustment for age, race, education, income
Model 4: adjustment for age, race, education, income, diabetes, hypertension, prevalent CHD
Model 5: adjustment for age, race, education, income, diabetes, hypertension, prevalent CHD, vital exhaustion
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Table 3














Overall (n=1,985) 4 (2,7) 133.5 (30, 530) 80.4 31.2
Low anger (n=735) 4 (2,7) 138 (33, 535) 79.9 30.1
Moderate anger (n=1,056) 3 (2,7) 128.5 (29, 530) 80.5 31.7
High anger (n=194) 4 (2,7) 124 (28, 510) 82.0 33.0
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Table 4
Multivariable estimates of the association of trait anger with the risk of all-cause re-hospitalization following 
incident HF. The ARIC Study cohort 1990–2010
Low anger Moderate anger High anger
n=735 n=1,056 n=194
Model 1 1 1.12 (1.00, 1.24) 1.17 (0.99, 1.40)
Model 2 1 1.12 (1.01, 1.25) 1.19 (1.00, 1.42)
Model 3 1 1.13 (1.01, 1.25) 1.20 (1.01, 1.43)
Model 4 1 1.14 (1.02, 1.27) 1.19 (1.01, 1.42)
*
Estimates adjusted for competing risk of death.
Model 1: unadjusted
Model 2: adjusted for age
Model 3: adjusted for age race gender
Model 4: adjusted for age race gender diabetes, hypertension, education
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